Literature DB >> 27278690

Autoimmune pancreatitis: with special reference to a localized variant.

Go Kobayashi1, Naotaka Fujita2, Yutaka Noda2, Kei Ito2, Jun Horaguchi2.   

Abstract

In 2006, the Japan Pancreas Society revised the diagnostic criteria for autoimmune pancreatitis (AIP) so as to more clearly define its morphological, pathological, and immunological features, as follows: (1) diffuse or segmental narrowing of the main pancreatic duct with an irregular wall and diffuse or localized enlargement of the pancreas recognized by imaging studies; (2) high serum gamma globulin, IgG, or IgG4 levels, or the presence of autoantibodies; and (3) marked interlobular fibrosis and prominent infiltration of lymphocytes and plasma cells in the periductal area, occasionally with lymphoid follicles in the pancreas. Establishing a diagnosis of AIP has become easier with knowledge of its immunological abnormalities, including serum IgG4 levels. However, the localized form of AIP sometimes mimics pancreatic cancer. The rate of focal mass formation in patients with AIP is reportedly 24%-43%; however, there have been few reports on the histological findings of localized AIP, in contrast to mass-forming pancreatitis (MFP). Our review of patients who had undergone resection due to a preoperative diagnosis of MFP with possible cancer revealed 72% to be patients with localized AIP. For the discrimination of these conditions, it is important to recognize the characteristic ultrasonographic findings of AIP, i.e., (1) diffuse or localized enlargement and hypoechogenicity of the pancreas; (2) rarity of calcification, cystic lesions, and peripancreatic fluid collection; (3) thickened layer structure of the bile duct wall; (4) iso/hypervascularity in the swollen portion of the pancreas; (5) attenuation of pancreatic swelling and bile duct wall thickening after steroid therapy; and (6) multiple hypoechoic masses in various organs, including the pancreas. Contrast-enhanced endoscopic ultrasonography is potentially a useful tool in the differential diagnosis and for assessment of the efficacy of steroid therapy by enabling evaluation of the vascularity of the lesions. Along with the presence of IgG4-positive plasma cells, verification of obliterative phlebitis is highly specific for the histological diagnosis of AIP.

Entities:  

Keywords:  IgG4; autoimmune pancreatitis; contrast-enhanced ultrasonography; mass-forming pancreatitis; obliterative phlebitis

Year:  2008        PMID: 27278690     DOI: 10.1007/s10396-008-0177-z

Source DB:  PubMed          Journal:  J Med Ultrason (2001)        ISSN: 1346-4523            Impact factor:   1.314


  56 in total

Review 1.  Chronic pancreatitis caused by an autoimmune abnormality. Proposal of the concept of autoimmune pancreatitis.

Authors:  K Yoshida; F Toki; T Takeuchi; S Watanabe; K Shiratori; N Hayashi
Journal:  Dig Dis Sci       Date:  1995-07       Impact factor: 3.199

2.  Pseudotumorous pancreatitis.

Authors:  J Lammer; H Herlinger; G Zalaudek; H Hofler
Journal:  Gastrointest Radiol       Date:  1985

3.  Differentiation of benign from malignant pancreatic masses by endoscopic ultrasound.

Authors:  P L Baron; L E Aabakken; D J Cole; M B LeVeen; L F Baron; D M Daniel; J T Cunningham; R H Hawes; D B Adams; B J Hoffman
Journal:  Ann Surg Oncol       Date:  1997-12       Impact factor: 5.344

4.  Histopathological study on mechanism and background of tumor-forming pancreatitis.

Authors:  M Takase; K Suda
Journal:  Pathol Int       Date:  2001-05       Impact factor: 2.534

5.  Multiple pancreatic masses associated with autoimmunity.

Authors:  M Ohana; K Okazaki; K Hajiro; Y Kobashi
Journal:  Am J Gastroenterol       Date:  1998-01       Impact factor: 10.864

6.  Prospective comparison of endoscopic ultrasound and endoscopic retrograde cholangiopancreatography in the preoperative assessment of masses in the pancreatic head.

Authors:  B Glasbrenner; M Schwarz; S Pauls; G Preclik; H G Beger; G Adler
Journal:  Dig Surg       Date:  2000       Impact factor: 2.588

7.  Distinct clinicopathological entity 'autoimmune pancreatitis-associated sclerosing cholangitis'.

Authors:  Takeshi Uehara; Hideaki Hamano; Shigeyuki Kawa; Kenji Sano; Takayuki Honda; Hiroyoshi Ota
Journal:  Pathol Int       Date:  2005-07       Impact factor: 2.534

8.  Histopathological features of diagnostic and clinical relevance in autoimmune pancreatitis: a study on 53 resection specimens and 9 biopsy specimens.

Authors:  Giuseppe Zamboni; Jutta Lüttges; Paola Capelli; Luca Frulloni; Giorgio Cavallini; Paolo Pederzoli; Alexander Leins; Daniel Longnecker; Günter Klöppel
Journal:  Virchows Arch       Date:  2004-10-27       Impact factor: 4.064

9.  IgG4-related sclerosing cholangitis with and without hepatic inflammatory pseudotumor, and sclerosing pancreatitis-associated sclerosing cholangitis: do they belong to a spectrum of sclerosing pancreatitis?

Authors:  Yoh Zen; Kenichi Harada; Motoko Sasaki; Yasunori Sato; Koichi Tsuneyama; Joji Haratake; Hiroshi Kurumaya; Kazuyoshi Katayanagi; Shinji Masuda; Hideki Niwa; Hideo Morimoto; Atsuo Miwa; Akio Uchiyama; Bernard C Portmann; Yasuni Nakanuma
Journal:  Am J Surg Pathol       Date:  2004-09       Impact factor: 6.394

10.  Ultrasonographic evaluation in patients with autoimmune-related pancreatitis.

Authors:  Naoko Hyodo; Takafumi Hyodo
Journal:  J Gastroenterol       Date:  2003       Impact factor: 7.527

View more
  2 in total

1.  Two cases of immunoglobulin G4-related sclerosing cholangitis in which transabdominal ultrasonography was useful in diagnosis and follow-up observation.

Authors:  Ikuhiro Kobori; Toshikuni Suda; Akihiro Nakamoto; Hiroki Saito; Osamu Okawa; Rion Sudo; Yoshinori Gyotoku; Yasumi Katayama; Masaya Tamano
Journal:  J Med Ultrason (2001)       Date:  2015-10-14       Impact factor: 1.314

Review 2.  From Pathogenesis, Clinical Manifestation, and Diagnosis to Treatment: An Overview on Autoimmune Pancreatitis.

Authors:  Ou Cai; Shiyun Tan
Journal:  Gastroenterol Res Pract       Date:  2017-01-19       Impact factor: 2.260

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.